Clinical Trials Browser

Phase 2 × abemaciclib × Other neoplasm × Clear all

NCT03531645 2026-03-05

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

Phase 2 Active not recruiting

Malignant Neoplasms of Female Genital Organs